Invention Grant
![Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitors](/docs/US/2018-01-02/US09856274B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitors
-
Application No.: US14884397Application Date: 2015-10-15
-
Publication No.: US09856274B2Publication Date: 2018-01-02
- Inventor: John Emmerson Campbell , Philip Jones , Michael Charles Hewitt
- Applicant: Sunovion Pharmaceuticals Inc.
- Applicant Address: US MA Marlborough
- Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee Address: US MA Marlborough
- Main IPC: A61K31/4353
- IPC: A61K31/4353 ; C07D487/04 ; C07D519/00 ; A61K45/06 ; C07D471/04 ; A61K31/4375 ; A61K31/4745 ; A61K31/4985 ; A61K31/519 ; A61K31/5383
![Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitors](/abs-image/US/2018/01/02/US09856274B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are substituted pyrazolopyridine compounds, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.
Public/Granted literature
- US20160102106A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2016-04-14
Information query
